Revista de la Sociedad Argentina de Diabetes (Aug 2015)

HYPERTENSION AND DIABETES: GUIDELINES FOR CLINICAL PRACTICE. 2015. HYPERTENSION AND OTHER FRCV-SAD COMMITTEE

  • Silvana Milrad,
  • Ángela Luongo,
  • Eva López,
  • Alicia García,
  • Solange Houssay,
  • Lidia Ruiz Morosini,
  • Cristina Varela,
  • Amelia Linari,
  • Claudio González,
  • Martha de Sereday,
  • Teresa Bensusan,
  • Gabriel Waissman,
  • Carolina Gómez Martín,
  • Hugo Sanabria,
  • Isac Sinay,
  • Cristina Grosso,
  • Fernando Krynski15,
  • Estrella Menéndez,
  • Agustín Ramírez,
  • Bárbara Arinovich Arinovich,
  • Carlos Busso,
  • Gloria Viñes,
  • Ramiro Sánchez,
  • Guillermo Burlando

DOI
https://doi.org/10.47196/diab.v49i2.201
Journal volume & issue
Vol. 49, no. 2
pp. 50 – 68

Abstract

Read online

Introduction: arterial hypertension (AH) and diabetes mellitus (DM) are chronic medical conditions of high prevalence, which are often associated. Conclusions: AH increases the progression and development of chronic micro and macro vascular complications related to DM. The impact of Hypertension treatment is highly significant in reducing morbidity and mortality in people with diabetes mellitus. Therefore, proper early treatment and therapeutic target goals should be individualized according to age group, comorbidities, and target organ damage. The goal is to achieve Blood Pressure (BP) <140/90 mmHg in all people suffering from AH, with or without DM and/or with Chronic Kidney disease (CKD). The BP target closer to130/80 mmHg should be considered in young people without comorbidities with long life expectancy and shorter diagnosis of DM: who will be benefited at renal level and whose stroke risk is substantial if achieved without treatment-related adverse effects. ACE inhibitors or ARBs are the drugs of choice, except in cases of intolerance or contraindication. A small percentage of people achieve the therapeutic goal. Proper educational activities are essential to improve adherence to treatment.

Keywords